Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,976,380
-$333,146 QoQ
Shares Held
7,854
-26.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,966
of 4,153 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESTFIELD CAPITAL MANAGEMENT CO LP holds $691,252,397 across 8 Drug Manufacturers - General names. ABBV ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
416,732 | $499,840,904 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,287,629 | $162,679,047 | |
| 3 | JNJ |
Johnson & Johnson
|
35,772 | $9,085,014 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,297 | $6,848,664 | |
| 5 | AMGN |
Amgen Inc
|
17,047 | $6,173,059 | |
| 6 | PFE |
Pfizer Inc
|
162,023 | $3,901,513 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
7,854 | $1,976,380 | |
| 8 | NVO |
Novo Nordisk A S
|
15,599 | $747,816 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,976,380 | 7,854 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,309,526 | 10,619 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $95,916,446 | 419,784 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,835,649 | 7,928 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $10,192,338 | 57,357 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $125,152,950 | 633,750 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $172,387,548 | 1,005,058 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $161,555,295 | 887,179 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $130,134,352 | 839,739 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $13,230,419 | 83,017 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,369,833 | 82,729 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,884,699 | 81,102 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,511,946 | 81,692 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,627,728 | 96,402 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,184,845 | 97,377 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,605,346 | 98,316 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,445,463 | 101,611 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $151,215,156 | 1,397,294 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $148,790,525 | 1,388,619 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||